News Release Biotricity CEO, Waqaas Al-Siddiq, to participate in panel discussion on the evolution of medical devices at the American Medical Device Summit on October 19th REDWOOD CITY, Calif., Oct 11, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityOctober 13, 2022
News Release Biotricity surpasses 2 billion recorded and analyzed heartbeats for atrial fibrillation (AFib) REDWOOD CITY, Calif., Oct 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityOctober 4, 2022
News Release Biotricity wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled real-time monitoring and predictive analytics for stroke due to chronic kidney failure REDWOOD CITY, Calif., Sep 07, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricitySeptember 7, 2022
News Release Biotricity to host Fiscal First Quarter 2023 financial results conference call on August 15th at 4:30 p.m. ET REDWOOD CITY, Calif., Aug 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityAugust 5, 2022
News Release Biotricity reports financial results for Fiscal 2022 fourth quarter and full year REDWOOD CITY, Calif., Jul 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityJuly 14, 2022
News Release Biotricity to join Russell Microcap(R) Index REDWOOD CITY, Calif., Jun 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityJune 23, 2022
News Release Biotricity to present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th REDWOOD CITY, Calif., May 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityMay 23, 2022
News Release Biotricity issues shareholder update REDWOOD CITY, Calif., May 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityMay 5, 2022
News Release Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022 REDWOOD CITY, Calif., Mar 22, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityMarch 22, 2022
News Release Biotricity named to Fast Company’s annual list of the World’s 50 Most Innovative Companies for 2022 REDWOOD CITY, Calif., Mar 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"),…biotricityMarch 8, 2022